Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Classical hematology 2Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 395Triple Negative Breast Neoplasms 63Ovarian Neoplasms 48Colorectal Neoplasms 36Prostatic Neoplasms 35Neoplasms 30Carcinoma, Non-Small-Cell Lung 30Endometrial Neoplasms 26Lung Neoplasms 24Neoplasm Metastasis 23Uterine Cervical Neoplasms 21Melanoma 19Stomach Neoplasms 17Pancreatic Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Carcinoma, Renal Cell 15Head and Neck Neoplasms 14Urinary Bladder Neoplasms 13Sarcoma 12Esophageal Neoplasms 11Colonic Neoplasms 11Advanced Breast Cancer 10Small Cell Lung Carcinoma 9Carcinoma, Transitional Cell 9Cholangiocarcinoma 8Anatomic Stage I Breast Cancer AJCC v8 8Liver Neoplasms 7Kidney Neoplasms 7Carcinoma, Hepatocellular 7Brain Neoplasms 6

Interventions

Tretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Breast × 30 days × Clear all
NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡